new_0222_0485|CGEM|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0485|CGEM|1|Cullinan Oncology Inc Total Current Assets (Quarterly) (USD)|Cullinan Oncology Inc Cash and Short Term Investments (Quarterly) (USD)|Cullinan Oncology Inc Inventories (Quarterly) (USD)|Cullinan Oncology Inc Net PP&E (Quarterly) (USD)|Cullinan Oncology Inc Goodwill and Intangibles (Quarterly) (USD)|Cullinan Oncology Inc Total Liabilities (Quarterly) (USD)|Cullinan Oncology Inc Total Current Liabilities (Quarterly) (USD)|Cullinan Oncology Inc Total Long Term Liabilities (Quarterly) (USD)|Cullinan Oncology Inc Total Deposits (Quarterly) (USD)|Cullinan Oncology Inc Book Value (Quarterly) (USD)|Cullinan Oncology Inc Retained Earnings (Quarterly) (USD)|Cullinan Oncology Inc Treasury Stock (Quarterly) (USD)|Cullinan Oncology Inc EV to Revenues|Cullinan Oncology Inc EV to Earnings|Cullinan Oncology Inc EV to Free Cash Flow|Cullinan Oncology Inc EV to Assets (Quarterly)|Cullinan Oncology Inc PS Ratio|Cullinan Oncology Inc PE Ratio|Cullinan Oncology Inc Price to Book Value|Cullinan Oncology Inc PEG Ratio|Cullinan Oncology Inc Debt to Equity Ratio|Cullinan Oncology Inc Dividend Yield|Cullinan Oncology Inc Shareholder Yield (TTM)|Cullinan Oncology Inc Percent of Shares Outstanding Short|Cullinan Oncology Inc Total Receivables (Quarterly) (USD)|Cullinan Oncology Inc Total Payables (Quarterly) (USD)|Cullinan Oncology Inc Total Capital Stock (Quarterly) (USD)|Cullinan Oncology Inc Return on Invested Capital|Cullinan Oncology Inc Quality Ratio Score|Cullinan Oncology Inc Momentum Score|Cullinan Oncology Inc Beta (1Y)|Cullinan Oncology Inc Sustainable Growth Rate (TTM)|Cullinan Oncology Inc Institutional Investor Ownership Percentage|Cullinan Oncology Inc Average Diluted Shares Outstanding (Quarterly)|Cullinan Oncology Inc Total Employees (Annual)|Cullinan Oncology Inc EPS Diluted (Quarterly) (USD)|Cullinan Oncology Inc SG&A Expense (Quarterly) (USD)|Cullinan Oncology Inc Shares Outstanding|Cullinan Oncology Inc Repurchase of Capital Stock (Quarterly) (USD)|Cullinan Oncology Inc Ordinary Shares Number (Quarterly)|Cullinan Oncology Inc Payout Ratio|Cullinan Oncology Inc Quick Ratio (Quarterly)|Cullinan Oncology Inc Normalized Diluted EPS (Quarterly) (USD)|Cullinan Oncology Inc Stock Buybacks (Quarterly) (USD)|Cullinan Oncology Inc Effective Tax Rate (TTM)|Cullinan Oncology Inc Return on Equity|Cullinan Oncology Inc Net Income (TTM) (USD)|Cullinan Oncology Inc Revenue (TTM) (USD)|Cullinan Oncology Inc Dividend Per Share (Quarterly) (USD)|Cullinan Oncology Inc Revenue (Quarterly) (USD)|Cullinan Oncology Inc Gross Profit (Quarterly) (USD)|Cullinan Oncology Inc Pre-Tax Income (Quarterly) (USD)|Cullinan Oncology Inc Net Income (Quarterly) (USD)|Cullinan Oncology Inc Net Interest Income (Quarterly) (USD)|Cullinan Oncology Inc Price (USD)|Cullinan Oncology Inc Total Return Price (USD)|Cullinan Oncology Inc Enterprise Value (USD)|Cullinan Oncology Inc 30-Day Average Daily Volume|Cullinan Oncology Inc 1 Year Price Returns (Daily)|Cullinan Oncology Inc Short Interest|Cullinan Oncology Inc PE Ratio (Forward)|Cullinan Oncology Inc PE Ratio (Forward 1y)|Cullinan Oncology Inc PS Ratio (Forward)|Cullinan Oncology Inc PS Ratio (Forward 1y)|Cullinan Oncology Inc Quarterly EPS Estimates (USD)|Cullinan Oncology Inc Quarterly Revenue Estimates (USD)|Cullinan Oncology Inc Quarterly EPS Surprise|Cullinan Oncology Inc Quarterly Revenue Surprise|Cullinan Oncology Inc Quarterly Actual EPS (USD)|Cullinan Oncology Inc Quarterly Actual Revenue (USD)|Cullinan Oncology Inc Revenue Estimates for Current Fiscal Year (USD)|Cullinan Oncology Inc Revenue Estimates for Next Fiscal Year (USD)|Cullinan Oncology Inc Price Target (USD)|Cullinan Oncology Inc Consensus Recommendation|Cullinan Oncology Inc Price Target Num Estimates|Cullinan Oncology Inc EPS Estimates for Current Fiscal Year (USD)|Cullinan Oncology Inc EPS Estimates for Next Fiscal Year (USD)|Cullinan Oncology Inc Research and Development Expense (Quarterly) (USD)|Cullinan Oncology Inc Reconciled Depreciation (Quarterly) (USD)|Cullinan Oncology Inc Non-Operating Interest Expense (Quarterly) (USD)|Cullinan Oncology Inc Land and Improvements (Quarterly) (USD)|Cullinan Oncology Inc Buildings and Improvements (Quarterly) (USD)|Cullinan Oncology Inc Other Properties (Quarterly) (USD)|Cullinan Oncology Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0485|CGEM|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0485|CGEM|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0485|CGEM|5|127.8|127.8||127.8||127.8|127.8|127.8||127.8|127.8||||1.44483985765|91.5|||1.44|||1.44483985765||15.24||127.8|127.8||||||30.4166666667|91.2857142857|136.5|91.2857142857|91.2857142857|29||127.8|||91.2857142857|91.3333333333|||91.25|||||91.2857142857|91.2857142857|91.2857142857|1.44483985765|1.44483985765|1.44483985765|1.43253968254|1.39285714286|15.24|||1.44483985765|1.44483985765|91.4285714286|91.25|91.5|90|91.5|91|31.0769230769|28.6153846154|24.8|12.8275862069|24.8|26.5|30.9166666667|91.2857142857|91.2857142857|||||183||
new_0222_0485|CGEM|6|5|5||5||5|5|5||5|5||||281|2|||225|||281||25||5|5||||||12|7|2|7|7|11||5|||7|6|||4|||||7|7|7|281|281|281|252|28|25|||281|281|7|8|2|1|2|3|13|13|15|29|15|14|12|7|7|||||2||
new_0222_0485|CGEM|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0485|CGEM|201912|100.091|98.63||0.182||140.37|2.523|137.847||-40.773|-41.54|||||||||||||||0.934|0.001|||||||19.3615||-0.236|1.177|||41.3978|||-0.236|||||||||-4.731|-4.569|0.252||||||||||||||||||||||||3.802|0.017|||||0.194||
new_0222_0485|CGEM|202003||||||||||||||||||||||||||||||||||19.3615||-0.2569|1.368||||||-0.2569|-14.25||||||||-5.163|-4.973|0.378||||||||||||||||||||||||4.173|0.016|||||||
new_0222_0485|CGEM|202006||||||||||||||||||||||||||||||||||19.3615||-0.4453|1.626||||||-0.4453|||||||||-13.875|-8.622|0.246||||||||||||||||||||||||12.496|0.016|||||||
new_0222_0485|CGEM|202009|221.73|219.592||0.146||7.806|7.732|0.074||212.348|-64.993|||||||||||||||3.487|0.003|||||||37.8312||-0.2606|1.586|||37.8312|||-0.2606||||-28.022|||||-11.314|-9.858|0.185||||||||||||||||||||||||9.913|0.015|||||0.204||
new_0222_0485|CGEM|202012|212.278|210.206||0.13||291.046|14.32|276.726||-77.642|-93.339||||-48.0987|||||||||0.811||9.679|0.001||||||3.6024|41.3978|26|-0.7493|12.544|37.8312||41.3978|||-0.7493|14.25|||-51.799|||||-29.106|-28.346|0.079|38.01|38.01|1432.4762|187891.6333||350195|||86.7139|763.4317||9||-100|||6|1.4333|47|1.75|4|-1.64|-1.87|16.629|0.015|||||0.204|40.42|
new_0222_0485|CGEM|202103|447.293|440.874||0.115||9.967|9.894|0.073||466.901|-93.409||||-52.3462|2.8671|||3.8837|||||4.9286||3.879|0.004||||||82.0115|41.9773||-0.0017|5.156|43.5161||43.5161||44.5597|-0.0017|-267.268|||-46.896|||18.943||1.419|-0.07|0.049|41.67|41.67|1375.2399|384805.9||2144755|||95.7973|843.4027|0.03|19|-100|-0.3||18.943|19|1.4333|47.25|1.75|4|-1.625|-2.11|12.415|0.015||||||32.46|29.73
new_0222_0485|CGEM|202106|344.467|336.705||0.102||5.813|5.743|0.07||455.549|-109.045||||-21.7319|1.6409|||2.4603|||||4.9454||1.51|0.004||||||87.8494|43.2954|28|-0.36|4.826|43.5262||43.5262|||-0.36||||-53.91|||||-16.439|-15.636|0.173|25.75|25.75|787.0856|303605.8||2152537|||59.2117|521.3022|-0.42||14.2857||-0.36||18.9465|1.4333|51.75|1.5|4|-1.3667|-1.9333|11.778|0.013||||||22.93|28.22
new_0222_0485|CGEM|202109|328.838|321.044||0.089||7.93|7.863|0.067||443.386|-126.395||||-17.6792|1.3894|||2.2225|||||5.9452||2.024|0.004||||||95.2026|43.4389|33|-0.4|5.695|43.6609||43.6609|||-0.4||||-61.402|||||-18.259|-17.35|0.118|22.57|22.57|666.4705|296362.9333||2595738|||52.06|458.3379|-0.435||-14.9425||-0.5||18.9287|1.4333|51.75|1.5|4|-1.2833|-1.96|12.68|0.013||||||22.22|18
new_0222_0485|CGEM|202112|||||||||||||||-9.4195||||1.5202|||||7.0628|||||||||97.289||||||||||||||||||||||15.43|15.43|355.0958|364459.8|-64.5356|3085331|||313.5125|313.5125|-0.4733||||||18.9287|2.15|51.75|1.5|4|-1.2775|-2.0733||||||||13.48|14.27
new_0222_0485|CGEM|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.475|||||||||||||||||||||
new_0222_0485|CGEM|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.46|||||||||||||||||||||
new_0222_0485|CGEM|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.445|4.3||||||||||||||||||||
new_0222_0485|CGEM|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.51|||||||||||||||||||||